Correlation Between ScinoPharm Taiwan and Apex Biotechnology
Can any of the company-specific risk be diversified away by investing in both ScinoPharm Taiwan and Apex Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScinoPharm Taiwan and Apex Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScinoPharm Taiwan and Apex Biotechnology Corp, you can compare the effects of market volatilities on ScinoPharm Taiwan and Apex Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScinoPharm Taiwan with a short position of Apex Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScinoPharm Taiwan and Apex Biotechnology.
Diversification Opportunities for ScinoPharm Taiwan and Apex Biotechnology
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ScinoPharm and Apex is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding ScinoPharm Taiwan and Apex Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Biotechnology Corp and ScinoPharm Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScinoPharm Taiwan are associated (or correlated) with Apex Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Biotechnology Corp has no effect on the direction of ScinoPharm Taiwan i.e., ScinoPharm Taiwan and Apex Biotechnology go up and down completely randomly.
Pair Corralation between ScinoPharm Taiwan and Apex Biotechnology
Assuming the 90 days trading horizon ScinoPharm Taiwan is expected to generate 1.02 times more return on investment than Apex Biotechnology. However, ScinoPharm Taiwan is 1.02 times more volatile than Apex Biotechnology Corp. It trades about 0.1 of its potential returns per unit of risk. Apex Biotechnology Corp is currently generating about 0.09 per unit of risk. If you would invest 2,225 in ScinoPharm Taiwan on November 28, 2024 and sell it today you would earn a total of 75.00 from holding ScinoPharm Taiwan or generate 3.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ScinoPharm Taiwan vs. Apex Biotechnology Corp
Performance |
| Timeline |
| ScinoPharm Taiwan |
| Apex Biotechnology Corp |
ScinoPharm Taiwan and Apex Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ScinoPharm Taiwan and Apex Biotechnology
The main advantage of trading using opposite ScinoPharm Taiwan and Apex Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScinoPharm Taiwan position performs unexpectedly, Apex Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Biotechnology will offset losses from the drop in Apex Biotechnology's long position.| ScinoPharm Taiwan vs. Syscom Computer Engineering | ScinoPharm Taiwan vs. WinMate Communication INC | ScinoPharm Taiwan vs. Shan Loong Transportation Co | ScinoPharm Taiwan vs. Wonderful Hi Tech Co |
| Apex Biotechnology vs. Grape King Bio | Apex Biotechnology vs. Standard Chemical Pharmaceutical | Apex Biotechnology vs. China Steel Chemical | Apex Biotechnology vs. Sinphar Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |